Source: PR Newswire

Press Release: Klogene Therapeutics : Klogene and Boston University Scientists are First to use CRISPR for Activation of the Life Extension and Cognition Enhancing Klotho Gene

BOSTON, Jan. 22, 2018 /PRNewswire/ -- In a paper published today in Journal of Molecular Neuroscience, scientists from Klogene Therapeutics, Inc. and Boston University School of Medicine showed efficient transcriptional activation of the anti-aging multifunctional gene Klotho by...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Carmela Abraham's photo - Co-Founder of Klogene Therapeutics

Co-Founder

Carmela Abraham

CEO Approval Rating

75/100

Read more